样式: 排序: IF: - GO 导出 标记为已读
-
Patient Education for CKD and Decision Support in Primary Care: Findings From the EPIK Pilot Study. Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-12-13 Julie Wright Nunes,Eve Kerr,Akinlolu Ojo,Corey Powell,Audrey Fan,F John Brinley,Anita Devine,Tammy Ellies,Katie Grzyb,Luis Garcia-Guzman,Tejpreet Nakai,Andrea Oliverio,Emily Chen,Angela Fagerlin
RATIONALE & OBJECTIVE Chronic kidney disease affects millions of people in the United States, yet effective interventions to address gaps in patient knowledge and engagement are not well established. We sought to develop and pilot a brief educational decision aid for patients with CKD cared for in primary care settings. STUDY DESIGN A pilot QI study of a decision aid intervention. SETTING & PARTICIPANTS
-
Glomerular Filtration of Creatinine: Validation of a Novel Index of Muscle Mass Among Older Adults. Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-12-12 Tatsufumi Oka,Lesley A Inker,Juhi Chaudhari,Hocine Tighiouart,Erin P Flanagin,Kristin Siggeirsdottir,Olafur S Indridason,Runolfur Palsson,Vilmundur G Gudnason,Andrew S Levey
RATIONALE & OBJECTIVE Low muscle mass is common among older adults and associated with poor prognosis. Quantifying muscle mass is challenging in routine clinical practice. We hypothesized that glomerular filtration of creatinine (GFcr) reflects muscle mass, and previously proposed estimated GFcr (eGFcr), as a practical index of muscle mass in older adults. This study investigated whether measured GFcr
-
Clinical Significance of Incident Osteoporotic Fractures After Kidney Transplantation: A National Korean Cohort Study. Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-12-12 Yunyoung Jang,Ji Eun Kim,Jina Park,Jeongin Song,Sehoon Park,Yong Chul Kim,Dong Ki Kim,Kwon Wook Joo,Yon Su Kim,Minsu Park,Hajeong Lee,Eunjeong Kang
RATIONALE & OBJECTIVE Recipients of kidney allografts are at risk for osteoporotic fractures (OF), but their association with patient and allograft outcomes remains uncertain due to common coexisting risks and complex medical conditions. This study sought to assess if overall incidence of OF among recipients of kidney allografts compared to patients receiving maintenance dialysis for kidney failure
-
Metformin in People With Diabetes and Advanced CKD: Should We Dare? Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-12-10 Jung-Im Shin,Antoine Créon,Juan-Jesus Carrero
-
Short-term Pains for Long-term Gains? In Search of More Solutions to Inequities in Kidney Transplantation. Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-12-06 Xingxing S Cheng
-
When a Loved One Faces Kidney Disease. Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-12-06 Swetha R Kanduri
-
Acute Kidney Injury in Care Transitions (ACT): A Randomized Controlled Feasibility Trial. Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-12-06 Erin F Barreto,Heather P May,Kristin C Cole,Joan M Griffin,Joseph R Herges,Kianoush B Kashani,Andrea G Kattah,Caroline B Ledet,Rozalina G McCoy,Angeliki G Tinaglia,Andrew D Rule,
-
Hemodialysis Vascular Access: Core Curriculum 2025. Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-12-02 Charmaine E Lok,Theodore Yuo,Timmy Lee
The majority of patients with kidney failure requiring replacement therapy will need the support of hemodialysis during their journey with kidney failure. A reliable functioning vascular access is required to provide hemodialysis. This Core Curriculum reviews the major forms of vascular access (arteriovenous fistula, arteriovenous graft, and central venous catheter) as well as the planning, preparation
-
A Young Woman With Nephrotic Syndrome: A Quiz. Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-12-01 Niloufar Ebrahimi,William Whittier,Yan Chen Wongworawat,Orhan Efe,Michifumi Yamashita,Amir Abdipour,Sahibzadi Mahrukh Noor,Lakshmi Ganesan,Sayna Norouzi
-
Establishing Research Priorities in Geriatric Nephrology: A Delphi Study of Clinicians and Researchers. Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-11-25 Catherine R Butler,Akanksha Nalatwad,Katharine L Cheung,Mary F Hannan,Melissa D Hladek,Emily A Johnston,Laura Kimberly,Christine K Liu,Devika Nair,Semra Ozdemir,Fahad Saeed,Jennifer S Scherer,Dorry L Segev,Anoop Sheshadri,Karthik K Tennankore,Tiffany R Washington,Dawn Wolfgram,Nidhi Ghildayal,Rasheeda Hall,Mara McAdams-DeMarco
RATIONALE & OBJECTIVE Despite substantial growth in the population of older adults with kidney disease, there remains a lack of evidence to guide clinical care for this group. The Kidney Disease and Aging Research Collaborative (KDARC) conducted a Delphi study to build consensus on research priorities for clinical geriatric nephrology. STUDY DESIGN Asynchronous modified Delphi study. SETTING & PARTICIPANTS
-
In Reply to “ACGME Accreditation for Transplant Nephrology Training: Clarifying Why This is a Step in the Right Direction” Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-11-22 Samira S. Farouk MD MS, Matthew A. Sparks MD, Fasika Tedla MD, Roslyn B. Mannon MD
-
Treatment Effect Heterogeneity in Acute Kidney Injury Incidence Following Intravenous Antihypertensive Administration for Severe Blood Pressure Elevation During Hospitalization. Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-11-21 Lama Ghazi,Xinyuan Chen,Michael O Harhay,Liangyuan Hu,Aditya Biswas,Aldo J Peixoto,Fan Li,F Perry Wilson
RATIONALE & OBJECTIVE Severe hypertension (sHTN) that develops after hospital admission is prevalent in 10% of patients admitted for reasons other than HTN. sHTN is commonly treated with intravenous (IV) antihypertensives and is associated with a greater risk of acute kidney injury (AKI). Our goal was to explore whether there is heterogeneity in IV antihypertensives' effect on AKI incidence among patients
-
Three Ankle-Brachial Index Ranges and Incident CKD in Diabetes: A Goldilocks Perspective on the “Just Right” Range Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-11-20 Houry Puzantian, Raymond R. Townsend
-
ACGME Accreditation for Transplant Nephrology Training: Clarifying Why This is a Step in the Right Direction. Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-11-19 Neeraj Singh,Michelle A Josephson,Vineeta Kumar,Roy D Bloom
-
Improved Survival in Patients Receiving Hemodialysis Through Changes in Practice Patterns: Does This Apply to Your Country? Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-11-15 Anneke Kramer, Rianne Boenink, Vianda S. Stel
-
Harmonizing the Different Perspectives on Growth Impairment in Pediatric CKD Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-11-15 Melissa S. Zhou, Alexander J. Wolf, Ken Sutha
-
Clinicopathologic, Proteomic and Outcome Characteristics of Renal Apolipoprotein C-II Amyloidosis: A Case Series. Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-11-13 Samih H Nasr,Surendra Dasari,Anthony M Valeri,Jason D Theis,Ann Moyer,Alessia Buglioni,M Barry Stokes,Linda Hasadsri,Julie A Vrana,Samar M Said,Satoru Kudose,Neeraja Kambham,Mei Lin Bissonnette,Lihong Bu,Renu Gupta,Attaya Suvannasankha,Suzanne Martin,Xu Zeng,Renuka Sothinathan,Adil Jadoon,Tewabe Kebede,Srimathi Manickaratnam,Jordan L Rosenstock,Glen S Markowitz,Sanjeev Sethi,Nelson Leung,Ellen D McPhail
RATIONALE & OBJECTIVE Amyloidosis derived from apolipoprotein C-II (AApoCII) is a recently discovered, rare form of amyloidosis. Data on clinical presentations and natural history are very limited. This study defines the clinicopathologic, proteomic and outcome characteristics of renal AApoCII. STUDY DESIGN Case series. SETTING & PARTICIPANTS Twenty-five renal AApoCII cases were identified from the
-
Trends in Kidney Allograft Failure Among First-Time Transplant Recipients in the United States. Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-11-07 Pascale Khairallah,Elizabeth C Lorenz,Amy Waterman,Nidhi Aggarwal,Akshta Pai,Wolfgang C Winkelmayer,Jingbo Niu
RATIONALE & OBJECTIVE The management and outcomes of kidney transplant recipients have evolved over the past three decades. This study of U.S patients whose first kidney allograft failed sought to understand long-term trends in subsequent waitlisting, re-transplantation, and all-cause mortality. STUDY DESIGN Retrospective cohort study. SETTING & PARTICIPANTS Patients recorded in the United States Renal
-
Stopping Versus Continuing Metformin in Patients With Advanced CKD: A Nationwide Scottish Target Trial Emulation Study Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-11-07 Emilie J. Lambourg PhD, Edouard L. Fu PhD, Stuart McGurnaghan PhD, Bryan R. Conway PhD, Neeraj Dhaun PhD, Christopher H. Grant MPH, Ewan R. Pearson PhD, Patrick B. Mark PhD, John Petrie PhD, Helen Colhoun PhD, Samira Bell MD, Scottish Diabetes Research Network Epidemiology Group, Rory McCrimmon, Catherine Armstrong, Alistair Emslie-Smith, Robert Lindsay, Sandra MacRury, John McKnight, Donald Pearson
Current guidance recommends against the use of metformin in people with advanced kidney impairment despite a lack of supporting evidence. The aim of this observational study was to compare outcomes of patients with type 2 diabetes who continued versus stopped metformin after developing stage 4 chronic kidney disease (CKD) (eGFR <30 ml/min/1.73m2).
-
Vadadustat Three Times Weekly in Patients With Anemia Due to Dialysis-Dependent CKD. Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-11-07 Hakan R Toka,Marializa Bernardo,Steven K Burke,Wenli Luo,Roberto Manllo-Karim,Irfan Ullah,Zhihui Yang,Zhiqun Zhang,James Tumlin
RATIONALE & OBJECTIVE Hypoxia-inducible factor prolyl hydroxylase inhibitors (HIF-PHIs) may offer an alternative erythropoiesis-stimulating agents (ESA) for the treatment of anemia in the setting of CKD. To investigate the efficacy and safety of conversion from long-acting erythropoiesis-stimulating agent (ESA) methoxy polyethylene glycol-epoetin beta (MPG-EPO) to the oral hypoxia-inducible factor
-
From Calculations to Care: The Impact of Changes in Kidney Function Estimation on a Patient's Experience of Care. Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-11-07 Kristine Marie Guevarra Almonte,Gregory D Mumford,Pipier Smith-Mumford,David Lee,Martha Pavlakis,Melanie Hoenig,Aditya S Pawar
-
Aiming for a Patient-Centered Organ Procurement and Transplantation Network Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-10-30 Sylvia E. Rosas, Morgan Reid
-
Exploring the Causal Relationship Between Kidney Function and Cancer Risk: Insights and Limitations of Mendelian Randomization Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-10-29 Sehoon Park, Jeong Min Cho, Dong Ki Kim
-
Proteinuria as an Endpoint in Clinical Trials of Focal Segmental Glomerulosclerosis. Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-10-23 Laura H Mariani,Howard Trachtman,Aliza Thompson,Barbara S Gillespie,Michelle Denburg,Ulysses Diva,Duvuru Geetha,Peter J Greasley,Michelle A Hladunewich,Robert B Huizinga,Jula K Inrig,Radko Komers,Louis-Philippe Laurin,Dustin J Little,Patrick H Nachman,Kimberly A Smith,Liron Walsh,Keisha L Gibson
Focal Segmental Glomerulosclerosis (FSGS) is a characteristic histopathological lesion that is indicative of underlying glomerular dysfunction. It is not a single disease entity but rather a heterogeneous disorder that is an important cause of nephrotic syndrome and kidney failure in children and adults. The aim of this Kidney Health Initiative project was to evaluate potential endpoints for clinical
-
Sex, Acute Kidney Injury, and Age: A Prospective Cohort Study. Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-10-22 Ladan Golestaneh,Abby Basalely,Andreas Linkermann,Tarek M El-Achkar,Ryung S Kim,Joel Neugarten
RATIONALE & OBJECTIVE Animal models of kidney disease suggest a protective role for female sex hormones but in humans, some authorities assert that female sex is a risk factor for acute kidney injury (AKI). To better understand the risk of AKI, we studied the strength of association between sex and AKI incidence in hormonally distinct age groups across the life span. STUDY DESIGN Prospective cohort
-
Intensive Home Blood Pressure Lowering in Patients With Advanced CKD Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-10-18 Elaine Ku, Timothy P. Copeland, Charles E. McCulloch, Divya Seth, Christopher A. Carlos, Kerry Cho, Anna Malkina, Lowell J. Lo, Raymond K. Hsu
Optimal blood pressure (BP) targets in advanced chronic kidney disease (CKD) are controversial. More intensive BP lowering in the setting of advanced CKD is thought to be associated with risk of acute kidney injury, hyperkalemia, and end-stage kidney disease. We conducted a pilot trial of intensive BP control to determine if lower home systolic BP (SBP) targets can be safely achieved for patients with
-
Three Cases of Red Yeast Rice–Containing Supplement-Induced Acute Kidney Injury and Fanconi Syndrome Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-10-16 Ayako Chikasue, Kensei Taguchi, Ryuji Iwatani, Koki Kimura, Seiya Okuda, Noriko Uesugi, Kei Fukami
Japan has recently faced a public health crisis owing to “Beni Koji Choleste Help,” a product marketed as a dietary supplement. It is made from red yeast rice and has cholesterol-lowering effects. Following the identification of the first case of acute kidney injury (AKI) caused by the product, 76 possibly related deaths and 492 hospitalizations have been reported in Japan. We herein demonstrate 3
-
Treatment of Autosomal Dominant Polycystic Kidney Disease. Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-10-16 Sara S Jdiaa,Reem A Mustafa,Alan S L Yu
Autosomal dominant polycystic kidney disease (ADPKD) is a chronic systemic disease that affects all races and ethnicities. It is the fourth leading cause of end-stage kidney disease, and it has a heterogenous phenotype ranging from mild to severe disease. Identifying patients with ADPKD who are at risk of rapid progression can guide therapeutic decisions. Several tools to predict disease severity are
-
Biomarkers of Rejection in Kidney Transplantation Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-10-16 Scott G. Westphal, Roslyn B. Mannon
Alloimmune injury is a major cause of long-term kidney allograft failure whether due to functionally stable (subclinical) or overt clinical rejection. These episodes may be mediated by immune cells (cellular rejection) or alloantibody (antibody-mediated rejection). Early recognition of immune injury is needed for timely appropriate intervention to maintain graft functional viability. However, the conventional
-
Forearm Versus Upper Arm Location of Arteriovenous Access Used at Hemodialysis Initiation: Temporal Trends and Racial Disparities Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-10-11 Melandrea L. Worsley, Jingbo Niu, Kevin F. Erickson, Neal R. Barshes, Wolfgang C. Winkelmayer, L. Parker Gregg
Race and ethnicity differences exist in the type of arteriovenous access (AVA, including fistulas and grafts) used at hemodialysis (HD) initiation. The preferred anatomic location for the creation of an initial HD AVA is typically in the forearm We evaluated race and ethnicity differences in the use of an AVA in the forearm location at HD initiation.
-
Laboratory Anomalies in the Basic Metabolic Panel: Core Curriculum 2025 Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-10-11 Layana T. Takieddine, Joe M. El-Khoury
Laboratory testing plays an integral part in medical decision making. However, laboratory results can sometimes vary significantly, leading to anomalous outcomes that are not consistent with the clinical picture. These anomalies can occur even in the best of laboratories simply because the total testing process includes elements that are not totally under the laboratory’s control. For example, variations
-
Blood Pressure Control and the Prevention of Incident CKD: The Disconnect Between Cohort Studies and Randomized Trials Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-10-11 Rajiv Agarwal
-
Viral Nephropathies: Core Curriculum 2024 Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-10-10 Amy A. Yau, Sangeetha Murugapandian, Ali W. Rizvi, Anna Gaddy
Viral-associated nephropathy is when kidney disease results from active viral replication. Because of the high global burden of viral infections, clinicians should be aware of their incidence, kidney manifestations, mechanism of injury, and management. Some viruses, such as hepatitis B, hepatitis C, human immunodeficiency virus (HIV), and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
-
Why Symptom Burden in Non-Dialysis CKD Matters Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-10-10 Meike Shedden-Mora, Birte Jessen, Tobias B. Huber
-
The Hidden Consequences of Kidney Disease on Body Image Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-10-10 Kassidy Thomas, Rayna Levitt RD
-
The OPTN Expeditious Task Force: Improved Organ Utilization and Efficiency to Drive Transformational Growth in Solid Organ Transplant in the United States Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-10-09 Alden Doyle, David Marshman
The Organ Procurement and Transplant Network (OPTN) Expeditious Task Force (ETF) was conceived and initiated in response to a need to move quickly to greatly expand successful deceased-donor transplant across the United States. The ETF, using data from the top 20% of transplant programs ranked by ability to manage successful growth in transplant volume, came up with a bold aim of facilitating 60,000
-
Considering Dialysis in Octogenarians and Nonagenarians Living With Kidney Failure. Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-10-06 Christina Miranda
-
Association of Coprescribing of Gabapentinoid and Other Psychoactive Medications With Altered Mental Status and Falls in Adults Receiving Dialysis Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-10-03 Rasheeda K. Hall, Sarah Morton-Oswald, Jonathan Wilson, Devika Nair, Cathleen Colón-Emeric, Jane Pendergast, Carl Pieper, Julia J. Scialla
Prescribing psychoactive medications for patients with kidney disease is common, but for patients receiving dialysis some medications may be inappropriate. We evaluated the association of coprescribing gabapentinoids and other psychoactive potentially inappropriate medications (PPIMs) (eg, sedatives or opioids) with altered mental status (AMS) and falls and whether the associations are modified by
-
Associations Among Circle-Based Kidney Allocation, Center Waiting Time, and Likelihood of Deceased-Donor Kidney Transplantation. Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-10-02 David C Cron,Arnold E Kuk,Layla Parast,S Ali Husain,Kristen L King,Miko Yu,Sumit Mohan,Joel T Adler
RATIONALE & OBJECTIVE The kidney allocation system (KAS250), using circle-based distribution, attempts to address geographic disparities through broader sharing of deceased-donor kidney allografts. This study sought to evaluate the association between KAS250 and likelihood of deceased-donor kidney transplantation (DDKT) among waitlisted candidates, and whether the policy has differentially affected
-
Leveraging the End-Stage Renal Disease Patient Life Goals Survey (PaLS) to Improve Quality of Care: Avoiding a “Checkbox Measure” Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-10-02 Samantha L. Gelfand, Joshua R. Lakin, Mallika L. Mendu
-
Medical Suitability and Willingness for Living Kidney Donation Among Older Adults. Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-10-01 Cédric Villain,Natalie Ebert,Richard J Glassock,Nina Mielke,Tim Bothe,Muhammad Helmi Barghouth,Anna Pöhlmann,Anne-Katrin Fietz,John S Gill,Elke Schaeffner
RATIONALE & OBJECTIVE The benefits of kidney transplantation compared with treatment with dialysis, including in older adults, are primarily limited by the number of donated kidneys. We studied the potential to expand the use of older living kidney donors. STUDY DESIGN Secondary analysis of the Berlin Initiative Study, a population-based cohort. SETTING & PARTICIPANTS 2,069 adults aged≥70 years in
-
A Case of Severe Acute Kidney Injury Due to an Antibiotic-Loaded Cement Spacer for Infected Knee Arthroplasty Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-10-01 Evan Finger, Larab Giniyani, Yevgeniy A. Korshunov, Jordan L. Rosenstock
The treatment for periprosthetic joint infection frequently involves the placement of a high-dose antibiotic-loaded bone cement spacer (ALCS) into the debrided joint. Typical antibiotics in the spacer include aminoglycosides and vancomycin. It has been believed that systemic absorption of intraarticular antibiotics would be low, and early experience suggested that the risk of acute kidney injury (AKI)
-
Urea to Treat Hyponatremia Due to Syndrome of Inappropriate Antidiuretic Hormone Secretion: A Systematic Review and Meta-Analysis Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-10-01 Subhash Chander, Roopa Kumari, Abhi Chand Lohana, Zubair Rahaman, Om Parkash, Sheena Shiwlani, Yaqub Nadeem Mohammed, Hong Yu Wang, Hao Chi, Wenchy Tan, Sanjay Kirshan Kumar, FNU Sindhu
The use of urea to treat hyponatremia related to the syndrome of inappropriate antidiuretic hormone secretion (SIADH) has not been universally adopted due to questions about effectiveness, safety, and tolerability. This systematic review and meta-analysis of observational studies addresses these questions.
-
Longitudinal Patterns of Ankle-Brachial Index and Their Association With Progression of CKD in Patients With Type 2 Diabetes and Elevated Body Mass Index Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-09-30 Mengyi Liu, Yanjun Zhang, Yuanyuan Zhang, Panpan He, Chun Zhou, Ziliang Ye, Sisi Yang, Xiaoqin Gan, Fan Fan Hou, Xianhui Qin
Ankle-brachial index (ABI) is used to screen for vascular complications in the setting of diabetes. This study sought to examine the relationship of longitudinal ABI data and chronic kidney disease (CKD) progression in patients with type 2 diabetes mellitus (T2DM) and increased body mass index.
-
Free Hormone Theory of Vitamin D Can Be an Important Alternative Consideration Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-09-27 Chia-Ter Chao MD PhD
-
Non-plasmapheresis Approaches for Managing Severe Renal Thrombotic Microangiopathy: A Report of 7 Cases Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-09-27 Marie Frimat, Mehdi Maanaoui, Nora Schwotzer, Celine Lebas, Arnaud Lionet, Sylvain Dubucquoi, Viviane Gnemmi, Fadi Fakhouri, François Provôt
C5-blockers are the established treatment for complement-mediated hemolytic uremic syndrome (CM-HUS). However, CM-HUS, lacking a definitive test, prompts plasma exchanges as a common first-line therapy, pending further assessments, despite complications and limited evidence in this indication. Recent experts’ opinion endorses C5-blockers as the initial treatment for severe renal thrombotic microangiopathy
-
Glucagon-like Peptide-1 Receptor Agonists: New Evidence of Kidney and Cardiovascular Protection From the FLOW and SELECT Trials Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-09-26 Maarten W. Taal, Nicholas M. Selby
-
Clinical Genetic Testing in Nephrology: Core Curriculum 2024 Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-09-26 Abraham W. Aron, Neera K. Dahl
Implementation of clinical genetic testing into the routine diagnostic workup of patients with kidney disorders can improve care when employed with proper patient selection. Due to advances in technology, testing with curated gene panels associated with kidney diseases are commercially available, are relatively inexpensive, and have quick turnaround time. While this may reduce barrier to entry, their
-
-
Identification of Nephrin Autoantibodies Signals New Chapter for Glomerular Disease Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-09-18 Clara J. Fischman, Lawrence B. Holzman
-
Social Connection: A Neglected Social Determinant of Health and an Opportunity to Improve Disease Management Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-09-13 Sanya Tinaikar, Sarah J. Schrauben
-
Steps in the Right Direction: The Importance of High-Quality Sex- and Gender-Based Analyses in CKD and Cardiovascular Disease Research Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-08-25 Kristin K. Clemens, Sofia B. Ahmed
-
Is Herbal Supplementation in Kidney Disease Ever Allowable? Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-08-24 Chia-Ter Chao
-
Peer Support Interventions for People With CKD: A Scoping Review Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-08-21 Meghan J. Elliott, Tyrone G. Harrison, Shannan Love, Paul E. Ronksley, Nancy Verdin, Dwight Sparkes, Caitrin O’Connor, Kate Manns, Sabrina Jassemi, Brenda R. Hemmelgarn, Maoliosa Donald
Formalized peer support is a promising approach for addressing the emotional and practical needs of people living with chronic kidney disease (CKD). We systematically identified and summarized peer support interventions studied in individuals with CKD with or without kidney replacement therapy (KRT).
-
Steps for Stopping Kidney Stones: Physical Activity Triumphant Over Genetics Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-08-18 Niharika Katkam, Srinivasan Beddhu
-
Super-Resolution Ultrasound to Assess Kidney Vascular Changes in Humans With Kidney Disease Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-08-16 Qiyang Chen PhD, Michael W George MD, Brenda McMahon BS, Joshua A. Rosenthal MD, Kang Kim PhD, Roderick J. Tan MD PhD
-
Progression of Coronary Artery Calcification and Risk of Clinical Events in CKD: The Chronic Renal Insufficiency Cohort Study Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-08-16 Ling Tian, Byron C. Jaeger, Julia J. Scialla, Matthew J. Budoff, Rupal C. Mehta, Bernard G. Jaar, Georges Saab, Mirela A. Dobre, Muredach P. Reilly, Daniel J. Rader, Raymond R. Townsend, James P. Lash, Philip Greenland, Tamara Isakova, Joshua D. Bundy, CRIC Study Investigators, Amanda H. Anderson, Lawrence J. Appel, Jing Chen, Debbie Cohen, Laura M. Dember, Alan S. Go, Robert G. Nelson, Mahboob Rahman
Coronary artery calcification (CAC) progresses rapidly in people with chronic kidney disease (CKD) compared with the general population. We studied the association between CAC progression and higher risks of atherosclerotic cardiovascular disease (CVD), congestive heart failure, and all-cause mortality among adults with CKD.
-
Effect of Dual RAAS Blockade and Intensive BP Lowering on Risk of End-Stage Kidney Disease and Death in Autosomal Dominant Polycystic Kidney Disease: Long-term Follow-up of the HALT-PKD Trials Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-08-16 Elaine Ku MD MAS, Timothy P. Copeland PhD, Charles E. McCulloch PhD, Kaleab Z. Abebe PhD, Michel Chonchol MD, Ronald D. Perrone MD, Frederic F. Rahbari-Oskoui MD, Alan S.L. Yu MD, Theodore Steinman MD, Arlene Chapman MD, Mark J. Sarnak MD MS
-
Patient, Parental, and Health Professional Perspectives on Growth in Children With CKD Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-08-09 Justin G. Wu, Chandana Guha, Anastasia Hughes, Luca G. Torrisi, Jonathan C. Craig, Aditi Sinha, Allison Dart, Allison A. Eddy, Detlef Bockenhauer, Hui-Kim Yap, Jaap Groothoff, Stephen I. Alexander, Susan L. Furth, Susan Samuel, Simon A. Carter, Amanda Walker, Joshua Kausman, Allison Jaure
Growth failure is a common problem among children with chronic kidney disease (CKD). Reduced height is associated with psychosocial burden, social stigma, and impaired quality of life. This study describes the aspects of growth impairment that are most impactful from the perspectives of children with CKD, their parents, and health professionals.
-
Explaining International Trends in Mortality on Hemodialysis Through Changes in Hemodialysis Practices in the Dialysis Outcomes and Practice Patterns Study (DOPPS) Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-08-09 Keith P. McCullough, Hal Morgenstern, Hugh C. Rayner, Friedrich K. Port, Michel Y. Jadoul, Tadao Akizawa, Ronald L. Pisoni, William H. Herman, Bruce M. Robinson, DOPPS 7 (2018-2021) Country Investigators, Dr. Ali Al-Aradi, Michel Jadoul, Pieter Evenepoel, Manish Sood, Rita Suri, Li Zuo, Yuqing Chen, Zhaohui Ni, Xiaonong Chen, Fanfan Hou, Xinling Liang, Christian Combe, Fitsum Guebre-Egziabher, Pablo
Case-mix adjusted hemodialysis mortality has decreased since 1998. Many factors that influence mortality may have contributed to this trend, and these associations may differ by continental region. We studied changes in hemodialysis facility practices over time and their potential role in mediating changes in patient survival.